2008 Lopinavir-ritonavir Monotherapy Versus Lopinavir-ritonavir... The Role of the Thymus in HIV Infection: A 10-Year Perspective... Survival Following HIV Infection of a Cohort... Antiretroviral Drugs and Liver Injury... 2007 Metabolic Syndrome, CVD, and Type 2 Diabetes After Start of ART Therapy... A Strategy for Accelerating the Development of Preventive AIDS Vaccines... Antiretroviral Therapy With Raltegravir Alters Decay Kinetics of HIV... Rapid Fibrosis Progression Among HIV/hepatitis C Virus-co-infected Adults... CYP2B6 Genetic Variants Are Associated With Nevirapine Pharmacokinetics... Perimortal Conditions and Mortality Rates Among HIV-infected Patients... Disparities in HIV Among Black and White Men Who Have Sex With Men... The EuroSIDA Risk-score... Results From the European CREAThE Network... PCP Prophylaxis May Not Be Required When Viral Replication Is Suppressed... Opinion: Stopping Antiretroviral Therapy (ART)... Should We Now Adopt the HIV-RNA < 50 Copy Endpoint for Clinical Trials?... A New Approach for 'Deep Salvage' Trials in Advanced HIV Infection... Antiretroviral Response to Darunavir/ritonavir and Etravirine Combination... The Role of Human Leukocyte Antigen E and G in HIV Infection... Editorial: Men Who Have Sex With Men and Their HIV Epidemics in Africa... Slower CD4 Cell Decline Following Cessation of a 3 Month Course of HAART... Prognosis of HIV-1-infected Patients Up to 5 years After Start of HAART... Care of Patients Coinfected With HIV and Hepatitis C Virus... Evidence of a Decline in Transmitted HIV-1 Drug Resistance in the UK... The Role of Adipokines in Relation to HIV Lipodystrophy (HIVLD)... Triple-class ARV Resistance: Risk, Predictors Among HIV-1-infected Patients... Intensification of a Triple-nucleoside Regimen With Tenofovir or Efavirenz... Week 24 Efficacy, Safety of TMC114/ritonavir in HIV Patients... Efficacy and Safety of Etravirine (TMC125) in Patients With Resistant HIV-1... Negative Mucosal Synergy Between Herpes Simplex Type 2 and HIV... Hepatitis C Virus Infection is Associated With Insulin Resistance... Week-4 Viral Response to Tailor Treatment Duration in Hepatitis C Virus... Efficacy, Safety of TMC114/ritonavir in Treatment-experienced HIV Patients... Randomized Trial of 2 Simplified, Class-sparing Regimens for HIV... Adherence in Antiretroviral Therapy for HIV: Review of Qualitative Studies... FDA Analysis of Tipranavir Clinical Resistance in HIV-1-infected Patients... Intermittent Therapy for the Treatment of Chronic HIV Infection... Effects of Metformin and Rosiglitazone in HIV-infected Patients... Pharmacokinetic Comparison of Lamivudine, Stavudine and Nevirapine... 2006 The Level of Persistent HIV Viremia Does Not Increase... Impact of Suppressive Herpes Therapy on Genital HIV-1 RNA among Women... Ezetimibe, a Promising Lipid-lowering Agent for the Treatment of Dyslipidae... Histological Response to pegIFNa-2a Plus Ribavirin in HIV-hepatitis C... An Updated Systematic Overview of Triple Combination Therapy... Interactions Between HIV and Malaria in Non-pregnant Adults... Combination of Tenofovir and Lamivudine vs Tenofovir after Lamivudine... Risks of Atherosclerotic Events Versus Death from Other Antiretroviral Use... Lifestyle Modification Program in HIV Patients with Metabolic Syndrome... Effects of Atazanavir/ritonavir and Lopinavir/ritonavir on Glucose Uptake ... Short-term Antiviral Activity of TMC278 in Treatment-Naive HIV-1-Infected... Comparative Analysis of T-cell Turnover and Homeostatic Parameters... Relevance of Mental Health to HIV/AIDS Care... Risk Factors for Osteonecrosis in HIV-Infected Patients... Adult Antiretroviral Therapy Guidelines... HIV/AIDS Preventive Vaccine 'Prime-Boost' Phase III Trial... Omeprazole Effects in Healthy Males and Females... Disease Management with Entry Inhibitors... Impact of Hepatitis B in HIV Patients Naive for Antiretroviral Therapy... Effectiveness of HIV Prevention Strategies in Resource-Poor Countries... Relationship Between HAART Regimen and CD4 Cell Count Increases ... Pulmonary Disease in Patients with HIV on Antiretroviral Therapy... Herpes Simplex Virus Infection in Women in the WIHS... Antiretroviral Medications and Elevated Blood Pressure... HIV-1 Transmission for Parenteral Exposure and Blood Transfusion... Lamivudine in HIV-1 Patients with a 3TC Resistant Virus... Treatment in Patients with Multiple Virologic Failures... HIV-1 Pol Mutation Frequency by Subtype and Treatment Experience... Acute Renal Failure in Hospitalized Patients with HIV... The Maturing Immune System... Disease Progression in Patients with Virological Suppression ... Sustained Control of Viremia ... Prevention Interventions and HIV Risk Behaviors... Immune Restoration Syndrome in Tuberculosis and HIV Co-Infection... Atazanavir/Ritonavir Genotypic Resistance Score... 2005 Increase in the Death Rate From LRD in Patients With HIV?... Management of Depression and Anxiety in HIV-Infected Adults... AIDS Events Among Individuals Initiating HAART... Dose-Dependent Influence of Didanosine on Immune Recovery... Detection of Minor Populations of Drug-Resistant HIV-1... Glucose Metabolism, Lipid, and Body Fat Changes ... Effect of Atazanavir on Methadone in Opiate Addicted Patients... CPG 7909 Adjuvant Improves Hepatitis B Vaccine Seroprotection... Antiviral Activity and Safety of 873140, A Novel CCR5 Antagonist... Inhibitory Quotient of Boosted Protease Inhibitors & Viral Load... Insulin Resistance and ART - Multicenter AIDS Cohort Study... Growth Hormone Releasing Factor in HIV-Infected Patients... HIV Drug Resistance Acquired Through Superinfection... Early Virologic Failure in HIV-1 Infected Subjects on Didanosine... How Effectively Does HAART Restore Immune Responses to... Substitution of Nevirapine or Efavirenz for Protease Inhibitor... Interactions Between Antimalarial and Antiretroviral Drugs... Carotid Artery Intima-Media Thickness and HIV Infection:... Micronutrients: Current Issues for HIV Care Providers... High Levels of HPV-16 DNA Are Associated With High-Grade... Antiretroviral Therapies for Treatment-Experienced Patients:... Atazanavir Plus Ritonavir or Saquinavir, and Lopinavir/Ritonavir... Cardiovascular Disease in HIV-Positive Patients... Hepatitis B and HIV: Prevalence, AIDS Progression, Response to... Paradoxical CD4+ T-Cell Decline in HIV-Infected Patients With... Genotypic Resistance in Heavily Pretreated HIV-Infected Patients... Long Term Probability of Detection of HIV-1 Drug Resistance... Sensorimotor Dysfunction in HIV/AIDS: Effects of Antiretroviral ... Incidence and Risk Factors for Immune Reconstitution... Sex and the Course of HIV Infection in the Pre- and Highly... CD4 Cell-Monitored Treatment Interruption in Patients With a... Care of Patients With Chronic Hepatitis B and HIV Co-Infection... Effectiveness of Cotrimoxazole Prophylaxis on Mortality in Adult... Combining Fosamprenavir With Lopinavir/Ritonavir Substantially... Emergence of Antiretroviral Resistance in HIV-Positive Women... The Antiretroviral Rollout and Drug-Resistant HIV in Africa: ... 2004 Does Transient HAART During Primary HIV-1 Infection Lower the... Prognostic Value of Plasma HIV RNA Among Highly Active... The Effect of Hepatitis C on Progression to AIDS Before and... Special Considerations in the Initiation and Management of... Late Presenters in the Era of Highly Active Antiretroviral... Limited Benefit of Antiretroviral Resistance Testing... Immunologic and Clinical Responses to Highly Active ... Cost-Effectiveness of HIV Postexposure Prophylaxis Following... Proviral HIV-DNA Predicts Viral Rebound and Viral Setpoint After... Response to Highly Active Antiretroviral Therapy Varies With Age... Rate of Viral Rebound According to Specific Drugs... Metabolic Complications of HIV Therapy In Children... Persistence of Primary Drug Resistance Among Recently HIV-1... Immune Restoration Disease After Antiretroviral Therapy... SOLO: 48-Week Efficacy and Safety Comparison of Once-Daily ... The Prevalence of Antiretroviral Drug Resistance in the United ... Relationship Between Drug Resistance and HIV-1 Disease ... Is the Male Genital Tract Really a Sanctuary Site for HIV? ... Maternal Versus Paternal Inheritance of HLA Class I Alleles... Impact of Host Genetics on HIV Disease Progression and Treatment... Impact of Viral Hepatitis Co-Infection on Response to... Clinical Management of Treatment-Experienced, HIV-Infected... Reversibility of Lipoatrophy in HIV-Infected Patients 2 Years... Implementing Antiretroviral Therapy in Resource-Constrained... Which Nucleoside and Nucleotide Backbone Combinations... Outcomes After Two Years of Providing Antiretroviral Treatment... Is Antiretroviral Treatment of Primary HIV Infection Clinically ... Long-Term Safety and Durable Antiretroviral Activity of... GW433908/Ritonavir Once Daily in Antiretroviral Therapy-Naive... Evaluation of Nevirapine and/or Hydroxyurea With Nucleoside... Effect of Prolonged Discontinuation of Successful Antiretroviral... Early Correction of Cell Cycle Perturbations Predicts... Study of Adjunctive Etanercept in HIV-1-Associated Tuberculosis... Recombination Following Superinfection by HIV-1... Short-Term Risk of AIDS According to CD4 Cell Count and Load... Care of Patients With Hepatitis C and HIV Co-Infection... 2003 HIV-1-Infected Adults With Tuberculosis in the Era of HAART... An Open-Label Assessment of TMC 125... Monitoring of Long-Term Toxicities of HIV Treatments... Expanding Access to HIV Antiretroviral Therapy... Update on Chronic Hepatitis C in HIV/HCV-Coinfected Patients... Persistent Drug-Resistant Mutations and Treatment Interruptions ... Risk of Severe Hepatotoxicity Associated With Antiretroviral... Failures of 1 Week on, 1 Week off Antiretroviral Therapies... Time to Change Policy?... Triple Nucleoside Regimen Abacavir, Stavudine and Didanosine... High Adherence Doesn't Prevent HIV Drug Resistance Mutations... When Should Antiretroviral Therapy Be Started for HIV Infection?... Interpretation of Genotype for Resistance to Abacavir... Virological Rebound After Suppression... Prevalance and Characterization of Lamivudine-Resistant Hep B... Improved Thymopoietic Potential in Aviremic HIV Infected... Impaired Growth Hormone Secretion Correlates With Visceral... Response to Highly Active Antiretroviral Therapy Strongly... Therapy With Atazanavir Plus Saquinavir... Adherence Is Not a Barrier to Successful Antiretroviral Therapy ... High-Density Lipoprotein Concentrations and HIV Viral Load... Antiviral Activity of Tenofovir Disoproxil Fumarate in HIV-1 ... Improving Lopinavir Genotype Algorithm Through Pheno Correlation... Clade B HIV-1 Superinfection With Wild-Type Virus ... Statins and Fibrates for the Treatment of Hyperlipidaemia ... Phenotypic Susceptibility and Virological Outcome... A Survival Response to Modern Antiretroviral Therapy... Activity of Enfuvirtide-Based Antiretroviral Therapy ... Recent Observations on HIV Type-1 Infection in the Genital Tract... A Phase I/II Study of Nevirapine for Pre-Exposure Prophylaxis ... Persistence of Drug-Resistant HIV-1 ... Effects of Interleukin-2 Therapy ... Candidate HIV/AIDS Vaccines... HIV RNA in Plasma Rebounds Within Days ... HIV Burden in Blood and Tissue Are Correlated With Each Other ... A V106M Mutation in HIV-1 Clade C Viruses Exposed ...... Best of AIDS 2003: Epidemiology, Social, Cultural, and Political... Best of AIDS 2003: Epidemiology, Social, Cultural, and Political... Best of AIDS 2003: Epidemiology, Social, Cultural, and Political... Best of AIDS 2003: Epidemiology, Social, Cultural, and Political... Best of AIDS 2003: Epidemiology, Social, Cultural, and Political... 2002 Increased Risk of Lipoatrophy Under Stavudine ... Safe Deferral of Antiretroviral Therapy ... Residual HIV-Specific CD4 and CD8 T Cell Frequencies ... Utilization to Reduce Mother-to-Child Transmission ... HIV-Associated Sensory Neuropathies... A Prospective Study of Adherence and Viral Load ... Prevalence and Clinical Correlates of HIV Viremia... A Prospective Cohort Analysis ... Persistent Rise in Hepatitis C Virus RNA... No Association Between GB Virus-C Viremia and Virological ... A Pilot Study of Cidofovir ... Highly Active Antiretroviral Therapy ... Virological Failure at 52 Weeks Among HIV-Infected Patients ... Ambulatory HIV-infected Patients ... Resistance to Antiretroviral Agents ... Intermittent Viraemia in Patients With Initial Viral Suppression... Hyperlactataemia and Lactic Acidosis... Clinical Efficacy of Early Initiation of HAART... Tenofovir DF in Antiretroviral-Experienced Patients... Neurologic and Psychiatric Complications ... Use of Laboratory Tests and Clinical Symptoms... Rates of Non-AIDS-Defining Cancers in People With HIV Infection... 0007 Renal Disease and CKD in African-American HIV-Infected Participants... | 
